KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 122 filers reported holding KYMERA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $266,491 | -47.2% | 19,172 | -12.6% | 0.56% | -28.4% |
| Q2 2023 | $504,562 | -28.4% | 21,947 | -7.7% | 0.78% | -24.1% |
| Q1 2023 | $704,572 | +4.1% | 23,779 | -12.3% | 1.03% | +19.2% |
| Q4 2022 | $677,040 | -9.7% | 27,125 | -21.3% | 0.86% | +17.1% |
| Q3 2022 | $750,000 | +10.1% | 34,462 | -0.4% | 0.74% | +17.7% |
| Q2 2022 | $681,000 | -69.0% | 34,596 | -33.4% | 0.63% | -47.6% |
| Q1 2022 | $2,199,000 | -27.4% | 51,964 | +8.9% | 1.19% | +13.5% |
| Q4 2021 | $3,030,000 | +71.5% | 47,729 | +58.6% | 1.05% | +78.0% |
| Q3 2021 | $1,767,000 | +35.2% | 30,088 | +11.6% | 0.59% | +23.4% |
| Q2 2021 | $1,307,000 | – | 26,958 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,984,736 | $149,379,011 | 17.99% |
| Aquilo Capital Management, LLC | 629,411 | $15,710,099 | 5.90% |
| BVF INC/IL | 4,692,604 | $117,127,396 | 4.94% |
| Artal Group S.A. | 2,000,000 | $49,920 | 2.79% |
| Redmile Group, LLC | 2,673,837 | $66,738,972 | 2.73% |
| Avoro Capital Advisors LLC | 3,850,000 | $96,096,000 | 1.44% |
| Deer Management Co. LLC | 615,895 | $15,372,739 | 1.42% |
| AtonRa Partners | 27,125 | $677,040 | 0.86% |
| Rock Springs Capital Management LP | 1,227,779 | $30,645,364 | 0.74% |
| EcoR1 Capital, LLC | 796,093 | $19,870,481 | 0.60% |